Global Medical Devices Q2 2018
The leading medical device companies will aim to maintain strong revenue gains in emerging markets, particularly inChina, where growth in areas such as diagnostics remains high by global standards. Following tax reform in the US, large companiessuch as Medtronic will continue to repatriate future earnings outside the US over the next eight years. Several of the top ten largestmedical device companies, most notably Abbott, have used M&A to supplement organic growth initiatives and this is borne out inthe companies’ Q417 results.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook